Updated: Tuesday, 18 Aug 2009, 10:30 AM EDT
Published : Tuesday, 18 Aug 2009, 10:30 AM EDT
ALLEGAN, Mich. (WOOD) - Perrigo Company Tuesday announced its financial report for its fourth fiscal quarter and full fiscal year of 2009, which ended in June.
The Allegan-based business manufactures and markets over-the-counter drugs such as analgesics, cough/cold medicines, antacids, laxatives and nutritional products.
In a statement, the company highlighted these continuing operations for the full year --
Management expects full-year fiscal 2010 earnings from
continuing operations to be in a range of $2 to $2.12 per share, an
increase of 7-13 percent compared to adjusted fiscal 2009 EPS.
Perrigo's Chairman and CEO Joseph C. Papa said, "Our team is executing well -- growing market share, managing our supply chain, improving customer service levels, investing in quality and delivering strong returns. By bringing innovative new products to market today and continuing to invest in research and development for future launches, we continue to make quality healthcare more affordable at a time when consumers need to save money more than ever."
On the Net: